Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;10(1):1-7.
doi: 10.3233/jad-2006-10101.

Curcuminoids Enhance Amyloid-Beta Uptake by Macrophages of Alzheimer's Disease Patients

Affiliations

Curcuminoids Enhance Amyloid-Beta Uptake by Macrophages of Alzheimer's Disease Patients

Laura Zhang et al. J Alzheimers Dis. .

Abstract

Treatment of Alzheimer's disease (AD) is difficult due to ignorance of its pathogenesis. AD patients have defects in phagocytosis of amyloid-beta (1-42) (Abeta) in vitro by the innate immune cells, monocyte/macrophages and in clearance of Abeta plaques [5]. The natural product curcuminoids enhanced brain clearance of Abeta in animal models. We, therefore, treated macrophages of six AD patients and 3 controls by curcuminoids in vitro and measured Abeta uptake using fluorescence and confocal microscopy. At baseline, the intensity of Abeta uptake by AD macrophages was significantly lower in comparison to control macrophages and involved surface binding but no intracellular uptake. After treatment of macrophages with curcuminoids, Abeta uptake by macrophages of three of the six AD patients was significantly (P<0.001 to 0.081) increased. Confocal microscopy of AD macrophages responsive to curcuminoids showed surface binding in untreated macrophages but co-localization with phalloidin in an intracellular compartment after treatment. Immunomodulation of the innate immune system by curcuminoids might be a safe approach to immune clearance of amyloidosis in AD brain.

Similar articles

See all similar articles

Cited by 49 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback